Obicetrapib sodium is a cholesteryl ester transfer protein (CETP) inhibitor. CETP inhibitors substantially increase the concentration of high-density lipoprotein cholesterol (HDL-C), which may have a possible beneficial effect for cardiovascular disease risk reduction.
Molecular Weight:
744.58
CAS Number:
[866399-88-4]
Formula:
C32H30F9N4NaO5
Target:
Others
T68505
* VAT and and shipping costs not included. Errors and price changes excepted